Stock listing

NASDAQ:NTRP Neurotrope Inc Stock

Follow Neurotrope Inc into a list and get an email when it puts out news.

Delisted NASDAQ:NTRP no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:NTRP
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Latest news

Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals

Dec 2, 2020

Neurotrope, Inc. Approves Spin-Off of Neurotrope Bioscience, Inc. and Sets Record and Distribution Dates

Nov 20, 2020

Neurotrope Announces First Patient Dosed in Long-Term Clinical Trial of Bryostatin in Alzheimer's Disease

Oct 6, 2020

Neurotrope Shareholders to Own 49 Percent of Petros Under Revised Merger Agreement with Metuchen

Sep 30, 2020

Neurotrope Bioscience Announces Agreement with Worldwide Clinical Trials, to Conduct Ongoing Phase 2 Study of Bryostatin-1, Partially Funded by NIH, for Alzheimer's Disease

Jul 30, 2020

Neurotrope Announces Strategic Partnership with BryoLogyx for Supply of Synthetic Bryostatin-1 and Continuation of the National Cancer Institute (NCI) Trial for Childhood Leukemia

Jun 10, 2020

Neurotrope Launches New Long-Term Clinical Trial of Bryostatin with the National Institutes of Health for the Treatment of Patients with Alzheimer's Disease

May 28, 2020

Neurotrope Announces Investor Update Conference Call

May 26, 2020

Neurotrope and Metuchen Pharmaceuticals Announce Merger Agreement to Form Petros Pharmaceuticals, a Men's Health Company

May 18, 2020

Neurotrope Provides Corporate Update After Completing Bryostatin-1 Data Analysis for Advanced Alzheimer's Disease Trial

Jan 22, 2020

All Neurotrope Inc news

Decks

Neurotrope Inc on 6ix

News releases
21 in all · newest Dec 2, 2020 · oldest 2019
Decks
4 decks · latest Jan 8, 2018

Log in to ask 6ix AI your own questions about Neurotrope Inc.